FILE:BMY/BMY-8K-20030304163558.txt.gz
EVENTS:	Other events	Financial statements and exhibits
TEXT:
ITEM: Other events
ITEM: Financial statements and exhibits
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2003 BRISTOL-MYERS SQUIBB COMPANY (Exact Name of Registrant as Specified in its Charter) Delaware 1-1136 22-079-0350 (State or Other (Commission File (IRS Employer Jurisdiction of Number) Identification Incorporation) Number) 345 Park Avenue New York, NY, 10154 (Address of Principal Executive Office) Registrant's telephone number, including area code: (212) 546-4000 ================================================================================
ITEM 5. OTHER EVENTS. On February 27, 2003, the Registrant announced in a press release that it expects to release the results of the previously disclosed restatement of its financial statements on Monday, March 10, 2003. The Registrant also announced that it expects to file its amended 2001 Form 10-K and its third quarter 2002 10-Q on March 10, 2003. Incorporated herein by reference is the press release issued by the Registrant on February 27, 2003 attached hereto as Exhibit 99.1. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (a) Financial Statements of Business to be Acquired: Not Applicable. (b) Pro Forma Financial Information: Not Applicable. (c) Exhibits EXHIBIT NO. DESCRIPTION ----------- ----------- 99.1 Press Release dated February 27, 2003
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Bristol-Myers Squibb Company, By: /s/ SANDRA LEUNG -------------------------- Name: Sandra Leung Title: Secretary Date: March 4, 2003
EXHIBIT INDEX EXHIBIT NO. DESCRIPTION ----------- ----------- 99.1 Press Release dated February 27, 2003

EXHIBIT 99.1 [LOGO OF BRISTOL-MYERS SQUIBB COMPANY] CONTACT: Bob Laverty John Elicker Corporate Affairs Investor Relations (609) 252-5732 (212) 546-3775 bob.laverty@bms.com john.elicker@bms.com BRISTOL-MYERS SQUIBB TO ANNOUNCE RESULTS OF RESTATEMENT AND 2002 EARNINGS ON MARCH 10, 2003 NEW YORK, N.Y. (February 27, 2003) -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that it expects to release the results of the previously disclosed restatement of its financial statements on Monday, March 10, 2003. The company also expects to announce full year 2002 earnings on the same day. The company also stated that it expects to file its amended 2001 Form 10-K and its third quarter 2002 10-Q on March 10, 2003. The company expects that its 2002 10-K, which is required to be filed on March 31, 2003, will be filed on time. A conference call will be held on March 10 at 8 a.m. (EDT). Financial information will be reviewed and company executives will address inquiries from investors and analysts. Investors and the general public are invited to listen to a live webcast of the call at www.bms.com/ir or by dialing (913) 981-5510. A replay of the call will be available on March 10 beginning at 11:30 a.m. through 8 p.m. on March 31. You may access the replay at www.bms.com/ir or by dialing (402) 280-9013. Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life. ###


